Mitochondrial metabolic regulation of lung epithelium: alveolar generation and regeneration
肺上皮的线粒体代谢调节:肺泡的生成和再生
基本信息
- 批准号:10681479
- 负责人:
- 金额:$ 16.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-17 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:ATP Synthesis PathwayAcute Respiratory Distress SyndromeAddressAdipocytesAdultAffectAlveolarAnabolismAnimalsBiochemicalBiologicalBiological MarkersBirthBloodCategoriesCause of DeathCell AgingCell DeathCell ProliferationCellsCessation of lifeClinicalComplexCre lox recombination systemCritical CareDataDefectDevelopmentDiseaseEnvironmentEpigenetic ProcessEpithelial CellsEpitheliumFailureFunctional disorderFutureGenerationsGeneticGenomic DNAGoalsHematopoietic stem cellsHypoxemic Respiratory FailureIn VitroInfectionInfluenzaInfluenza A virusInjuryInstitutionIntrinsic factorK-Series Research Career ProgramsLaboratoriesLeadLifeLinkLungMentorsMentorshipMetabolicMethylationMitochondriaMitochondrial Electron Transport Complex IModelingMolecularNatural regenerationOrganellesOrganoidsOxygenPathway interactionsPatientsPhenotypePhysiciansPneumoniaProcessProductionProliferatingProteinsProton PumpReactive Oxygen SpeciesRegulationReportingResearchResearch PersonnelRespirationRespiratory ChainRoleScientistSignal TransductionStem cell pluripotencyStructureStructure of parenchyma of lungSupportive careSystemTechniquesTestingTrainingUnited StatesUniversitiesWorkadipocyte differentiationalveolar epitheliumcandidate identificationcareercell typeeffective therapyepithelial injuryepithelial repairepithelial stem cellgain of functioninducible Creinfluenza infectioninsightkeratinocytekeratinocyte differentiationloss of functionlung developmentlung injurylung regenerationlung repairmacromoleculemetabolic abnormality assessmentmetabolomicsmitochondrial dysfunctionmitochondrial metabolismmortalitymultidimensional datanew therapeutic targetnovelnovel therapeutic interventionnovel therapeuticspharmacologicpostnatalpreventrepairedreparative processresponsesepsis induced ARDSskillsstem cell differentiationstem cellssymposiumtherapeutic targettooltranscriptome sequencingyeast protein
项目摘要
Project Summary/Abstract
This application for a Mentored Clinical Scientist Research Career Development Award (K08) is being submitted
by SeungHye Han, MD, MPH, and entitled “Mitochondrial metabolic regulation of lung epithelium: alveolar
generation and regeneration.” I am a pulmonary and critical care physician at Northwestern University who is
obtaining additional training to build expertise as a physician scientist studying metabolic regulation of lung
development and repair after lung injury. My long-term research goal is to find new therapeutic targets to promote
lung repair in patients with acute respiratory distress syndrome (ARDS). The objective of my current project is to
study the role of mitochondrial complex I on postnatal lung development and lung repair after influenza infection,
and identify metabolites and pathways that link complex I driven respiration to lung stem/progenitor cells.
ARDS is a devastating disorder commonly associated with pneumonia and influenza infection, which are
categorized as one of the ten leading causes of death in the United States. The mortality rate is high from 30 to
45%, and there is no current effective therapy except supportive care. One novel therapeutic approach is to
promote lung repair after injury has occurred. Several lung epithelial subpopulations have been reported to
expand in response to various insults, and repopulate to replace damaged alveolar epithelial cells. Little is known
about how proliferation and differentiation are regulated in these epithelial stem/progenitor cells. My mentor Dr.
Chandel’s laboratory previously demonstrated that the mitochondrial respiratory chain is essential for the
differentiation of various cells including keratinocytes, adipocytes, and hematopoietic stem cells. These effects
are exerted through reactive oxygen species or the accumulation of mitochondrial metabolites that control
epigenetic machinery, and are independent of the ATP synthetic function of mitochondria. Whether lung epithelial
stem/progenitor cells are regulated by mitochondrial metabolism has not been studied. My preliminary data
suggest that mitochondrial complex I driven respiration is required for the differentiation of lung epithelial
stem/progenitor cells. These observations led to the novel hypothesis that mitochondrial complex I driven
respiration, independent of ATP generation, is necessary and sufficient for postnatal lung development via
metabolites (Aim 1), and is necessary for the repair of influenza-induced adult epithelial lung injury (Aim 2).
My project will provide a new mechanistic model linking mitochondrial metabolism to lung epithelial
stem/progenitor cells in the context of lung injury and repair. The training plan will promote acquisition of key
metabolic and biochemical laboratory skills, proficiency with conducting animal studies, and interpretation of high
throughput data from high dimensional (-omic) platforms. The activities planned in this proposal, including
guidance with close mentorship, attendance of conferences, and completion of coursework in a research-
intensive institutional environment, will further my continued development into an independent researcher.
项目总结/摘要
本申请为指导临床科学家研究职业发展奖(K 08)正在提交
SeungHye Han,医学博士,公共卫生硕士,题为“肺上皮细胞的线粒体代谢调节:肺泡
再生与再生”。我是西北大学的一名肺病和重症监护医生,
获得额外的培训,以建立作为研究肺代谢调节的医生科学家的专业知识
肺损伤后的发展和修复。我的长期研究目标是寻找新的治疗靶点来促进
急性呼吸窘迫综合征(ARDS)患者的肺修复。我目前项目的目标是
研究线粒体复合物I在出生后肺发育和流感感染后肺修复中的作用,
并鉴定将复合物I驱动的呼吸与肺干/祖细胞联系起来的代谢物和途径。
ARDS是一种破坏性疾病,通常与肺炎和流感感染相关,
被列为美国十大死亡原因之一。死亡率从30岁到
45%,目前除支持治疗外无有效治疗。一种新的治疗方法是
促进肺损伤后的修复。据报道,几种肺上皮细胞亚群
对各种损伤作出反应而扩增,并重新繁殖以取代受损的肺泡上皮细胞。知之甚少
关于这些上皮干/祖细胞的增殖和分化是如何调节的。我的导师博士
Chandel的实验室先前证明,线粒体呼吸链对呼吸系统的功能至关重要。
在一些实施方案中,本发明的组合物用于促进包括角质形成细胞、脂肪细胞和造血干细胞的各种细胞的分化。这些影响
是通过活性氧或线粒体代谢物的积累发挥作用的,
表观遗传机制,并独立于线粒体的ATP合成功能。是否肺上皮
干/祖细胞受线粒体代谢调节的研究尚未进行。我的初步数据
提示线粒体复合物I驱动呼吸是肺上皮细胞分化所必需的,
干/祖细胞。这些观察结果导致了一个新的假设,即线粒体复合物I驱动
呼吸,独立于ATP的产生,是出生后肺发育所必需和充分的,
代谢产物(目的1),是必要的流感诱导的成人上皮肺损伤的修复(目的2)。
我的项目将提供一个新的机制模型连接线粒体代谢肺上皮细胞
干/祖细胞在肺损伤和修复的背景下。该培训计划将促进获得关键的
代谢和生化实验室技能,熟练进行动物研究,并解释高
来自高维(-omic)平台的通量数据。本提案中计划的活动,包括
指导与密切的导师,出席会议,并完成课程的研究-
密集的制度环境,将进一步我继续发展成为一个独立的研究人员。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Unveiling an Important New Cell Type in the Lung: Microfold Cells.
揭示肺中一种重要的新细胞类型:微折叠细胞。
- DOI:10.1165/rcmb.2024-0002ed
- 发表时间:2024
- 期刊:
- 影响因子:6.4
- 作者:Han,SeungHye
- 通讯作者:Han,SeungHye
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seunghye Han其他文献
Seunghye Han的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seunghye Han', 18)}}的其他基金
Mitochondrial metabolic regulation of lung epithelium: alveolar generation and regeneration
肺上皮的线粒体代谢调节:肺泡的生成和再生
- 批准号:
10241362 - 财政年份:2019
- 资助金额:
$ 16.33万 - 项目类别:
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 16.33万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:














{{item.name}}会员




